Phase III safety and efficacy data of TRADJENTA® (linagliptin) tablets in elderly people with type 2 diabetes published in The Lancet Linagliptin, which is marketed as TRADJENTA ® (linagliptin) ...
RIDGEFIELD, Conn., and INDIANAPOLIS, March 23, 2015 /PRNewswire/ -- Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading ...
Taking antidepressants and NSAIDs together may raise risk of intracranial hemorrhage. Patients taking linagliptin had decreased HbA1c as well as reactive oxygen species generation and plasma lipid ...
If you have type 2 diabetes, your doctor might suggest Tradjenta (linagliptin) as a treatment option. It’s a prescription medication used to help manage blood sugar levels in adults with type 2 ...
Tradjenta bottle Boehringer Ingelheim and Lilly announced that the CAROLINA trial met its primary endpoint, demonstrating no increased cardiovascular (CV) risk with linagliptin, a dipeptidyl peptidase ...
Tradjenta (linagliptin) is a prescription oral tablet that’s used to treat type 2 diabetes in adults. Tradjenta’s cost may depend on factors such as whether you have health insurance and the pharmacy ...
Boehringer Ingelheim and Eli Lilly and Company announced CAROLINA (CARdiovascular Outcome study of LINAgliptin versus glimepiride in patients with type 2 diabetes) met its primary endpoint, defined as ...
RIDGEFIELD, Conn. and INDIANAPOLIS, July 19, 2018 /PRNewswire/ -- CARMELINA ® (CArdiovascular safety and Renal Microvascular outcomE with LINAgliptin in patients with type 2 diabetes at high vascular ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — A head-to-head comparison of the sulfonylurea glimepiride against the DPP-IV inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results